Cargando…

Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom

BACKGROUND: To estimate the potential gain in life expectancy from addressing modifiable risk factors for all-cause mortality (excluding suicide and deaths from accidents or violence) across specific serious mental illness (SMI) subgroups, namely schizophrenia, schizoaffective disorders, and bipolar...

Descripción completa

Detalles Bibliográficos
Autores principales: Dregan, Alex, McNeill, Ann, Gaughran, Fiona, Jones, Peter B., Bazley, Anna, Cross, Sean, Lillywhite, Kate, Armstrong, David, Smith, Shubulade, Osborn, David P. J., Stewart, Robert, Wykes, Til, Hotopf, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100972/
https://www.ncbi.nlm.nih.gov/pubmed/32218598
http://dx.doi.org/10.1371/journal.pone.0230674
_version_ 1783511527072989184
author Dregan, Alex
McNeill, Ann
Gaughran, Fiona
Jones, Peter B.
Bazley, Anna
Cross, Sean
Lillywhite, Kate
Armstrong, David
Smith, Shubulade
Osborn, David P. J.
Stewart, Robert
Wykes, Til
Hotopf, Matthew
author_facet Dregan, Alex
McNeill, Ann
Gaughran, Fiona
Jones, Peter B.
Bazley, Anna
Cross, Sean
Lillywhite, Kate
Armstrong, David
Smith, Shubulade
Osborn, David P. J.
Stewart, Robert
Wykes, Til
Hotopf, Matthew
author_sort Dregan, Alex
collection PubMed
description BACKGROUND: To estimate the potential gain in life expectancy from addressing modifiable risk factors for all-cause mortality (excluding suicide and deaths from accidents or violence) across specific serious mental illness (SMI) subgroups, namely schizophrenia, schizoaffective disorders, and bipolar disorders in a Western population. METHODS: We have used relative risks from recent meta-analyses to estimate the population attribution fraction (PAF) due to specific modifiable risk factors known to be associated with all-cause mortality within SMI. The potential gain in life expectancy at birth, age 50 and age 65 years were assessed by estimating the combined effect of modifiable risk factors from different contextual levels (behavioural, healthcare, social) and accounting for the effectiveness of existing interventions tackling these factors. Projections for annual gain in life expectancy at birth during a two-decade was estimated using the Annual Percentage Change (APC) formula. The predicted estimates were based on mortality rates for year 2014–2015. RESULTS: Based on the effectiveness of existing interventions targeting these modifiable risk factors, we estimated potential gain in life expectancy at birth of four (bipolar disorders), six (schizoaffective disorders), or seven years (schizophrenia). The gain in life expectancy at age 50 years was three (bipolar disorders) or five (schizophrenia and schizoaffective disorders) years. The projected gain in life expectancy at age 65 years was three (bipolar disorders) or four (schizophrenia and schizoaffective disorders) years. CONCLUSIONS: The implementation of existing interventions targeting modifiable risk factors could narrow the current mortality gap between the general and the SMI populations by 24% (men) to 28% (women). These projections represent ideal circumstances and without the limitation of overestimation which often comes with PAFs.
format Online
Article
Text
id pubmed-7100972
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-71009722020-04-03 Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom Dregan, Alex McNeill, Ann Gaughran, Fiona Jones, Peter B. Bazley, Anna Cross, Sean Lillywhite, Kate Armstrong, David Smith, Shubulade Osborn, David P. J. Stewart, Robert Wykes, Til Hotopf, Matthew PLoS One Research Article BACKGROUND: To estimate the potential gain in life expectancy from addressing modifiable risk factors for all-cause mortality (excluding suicide and deaths from accidents or violence) across specific serious mental illness (SMI) subgroups, namely schizophrenia, schizoaffective disorders, and bipolar disorders in a Western population. METHODS: We have used relative risks from recent meta-analyses to estimate the population attribution fraction (PAF) due to specific modifiable risk factors known to be associated with all-cause mortality within SMI. The potential gain in life expectancy at birth, age 50 and age 65 years were assessed by estimating the combined effect of modifiable risk factors from different contextual levels (behavioural, healthcare, social) and accounting for the effectiveness of existing interventions tackling these factors. Projections for annual gain in life expectancy at birth during a two-decade was estimated using the Annual Percentage Change (APC) formula. The predicted estimates were based on mortality rates for year 2014–2015. RESULTS: Based on the effectiveness of existing interventions targeting these modifiable risk factors, we estimated potential gain in life expectancy at birth of four (bipolar disorders), six (schizoaffective disorders), or seven years (schizophrenia). The gain in life expectancy at age 50 years was three (bipolar disorders) or five (schizophrenia and schizoaffective disorders) years. The projected gain in life expectancy at age 65 years was three (bipolar disorders) or four (schizophrenia and schizoaffective disorders) years. CONCLUSIONS: The implementation of existing interventions targeting modifiable risk factors could narrow the current mortality gap between the general and the SMI populations by 24% (men) to 28% (women). These projections represent ideal circumstances and without the limitation of overestimation which often comes with PAFs. Public Library of Science 2020-03-27 /pmc/articles/PMC7100972/ /pubmed/32218598 http://dx.doi.org/10.1371/journal.pone.0230674 Text en © 2020 Dregan et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Dregan, Alex
McNeill, Ann
Gaughran, Fiona
Jones, Peter B.
Bazley, Anna
Cross, Sean
Lillywhite, Kate
Armstrong, David
Smith, Shubulade
Osborn, David P. J.
Stewart, Robert
Wykes, Til
Hotopf, Matthew
Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom
title Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom
title_full Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom
title_fullStr Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom
title_full_unstemmed Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom
title_short Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom
title_sort potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the united kingdom
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100972/
https://www.ncbi.nlm.nih.gov/pubmed/32218598
http://dx.doi.org/10.1371/journal.pone.0230674
work_keys_str_mv AT dreganalex potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom
AT mcneillann potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom
AT gaughranfiona potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom
AT jonespeterb potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom
AT bazleyanna potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom
AT crosssean potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom
AT lillywhitekate potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom
AT armstrongdavid potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom
AT smithshubulade potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom
AT osborndavidpj potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom
AT stewartrobert potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom
AT wykestil potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom
AT hotopfmatthew potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom